These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12444359)

  • 41. Exploring the costs and economic consequences of unsafe abortion in Mexico City before legalisation.
    Levin C; Grossman D; Berdichevsky K; Diaz C; Aracena B; Garcia SG; Goodyear L
    Reprod Health Matters; 2009 May; 17(33):120-32. PubMed ID: 19523589
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Understanding clinical complexity in delinquent youth: comorbidities, service utilization, cost, and outcomes.
    Hussey DL; Drinkard AM; Falletta L; Flannery DJ
    J Psychoactive Drugs; 2008 Mar; 40(1):85-95. PubMed ID: 18472668
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Economic costs of Oxford House inpatient treatment and incarceration: a preliminary report.
    Olson BD; Viola J; Jason LA; Davis MI; Ferrari JR; Rabin-Belyaev O
    J Prev Interv Community; 2006; 31(1-2):63-72. PubMed ID: 16595387
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of the Addiction Severity Index (ASI) and the Global Appraisal of Individual Needs (GAIN) in predicting the effectiveness of drug treatment programs for pregnant and postpartum women.
    Coleman-Cowger VH; Dennis ML; Funk RR; Godley SH; Lennox RD
    J Subst Abuse Treat; 2013 Jan; 44(1):34-41. PubMed ID: 22436533
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drug addict rehabilitation: a burden on society?
    Berg JE; Andersen S
    Int J Rehabil Res; 1992; 15(4):301-9. PubMed ID: 1336768
    [No Abstract]   [Full Text] [Related]  

  • 46. Treatment of substance abuse during pregnancy and infant outcome.
    Little BB; Snell LM; Van Beveren TT; Crowell RB; Trayler S; Johnston WL
    Am J Perinatol; 2003 Jul; 20(5):255-62. PubMed ID: 13680509
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost-effectiveness of treatment for drug-abusing pregnant women.
    Svikis DS; Golden AS; Huggins GR; Pickens RW; McCaul ME; Velez ML; Rosendale CT; Brooner RK; Gazaway PM; Stitzer ML; Ball CE
    Drug Alcohol Depend; 1997 Apr; 45(1-2):105-13. PubMed ID: 9179512
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Substance abuse treatment for mothers: treatment outcomes and the impact of length of stay.
    Conners NA; Grant A; Crone CC; Whiteside-Mansell L
    J Subst Abuse Treat; 2006 Dec; 31(4):447-56. PubMed ID: 17084800
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.
    Spottke EA; Volkmann J; Lorenz D; Krack P; Smala AM; Sturm V; Gerstner A; Berger K; Hellwig D; Deuschl G; Freund HJ; Oertel WH; Dodel RC
    J Neurol; 2002 Jun; 249(6):759-66. PubMed ID: 12111311
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The cost of residential addiction treatment in public housing.
    Alexandre PK; Roebuck MC; French MT; Barry M
    J Subst Abuse Treat; 2003 Jun; 24(4):285-90. PubMed ID: 12867201
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Costs and benefits of treatment for cocaine addiction in DATOS.
    Flynn PM; Kristiansen PL; Porto JV; Hubbard RL
    Drug Alcohol Depend; 1999 Dec; 57(2):167-74. PubMed ID: 10617100
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Out of touch or on the money: Do the clinical objectives of addiction treatment coincide with economic evaluation results?
    Dismuke CE; French MT; Salomé HJ; Foss MA; Scott CK; Dennis ML
    J Subst Abuse Treat; 2004 Oct; 27(3):253-63. PubMed ID: 15501378
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integrated treatment programs for pregnant and parenting women with problematic substance use: Service descriptions and client perceptions of care.
    Tarasoff LA; Milligan K; Le TL; Usher AM; Urbanoski K
    J Subst Abuse Treat; 2018 Jul; 90():9-18. PubMed ID: 29866387
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changes in Residential Substance Use Treatment Service Access Resulting From Recent Medicaid Section 1115 Waivers.
    Miles J
    Psychiatr Serv; 2019 May; 70(5):428-431. PubMed ID: 30755128
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Making lemonade out of lemons: a case report and literature review of external pressure as an intervention with pregnant and parenting substance-using women.
    Davis KJ; Yonkers KA
    J Clin Psychiatry; 2012 Jan; 73(1):51-6. PubMed ID: 22316576
    [No Abstract]   [Full Text] [Related]  

  • 56. Accountability in public short-term adult AOD residential treatment. Fontainebleau Treatment Center.
    Hyde A; Vollmerhausen S
    J Subst Abuse Treat; 1998; 15(4):367-75. PubMed ID: 9650146
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison of the cost-effectiveness of day treatment and residential treatment for children with severe behaviour problems.
    Grizenko N; Papineau D
    Can J Psychiatry; 1992 Aug; 37(6):393-400. PubMed ID: 1394015
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug dependence during pregnancy. Effect of an on-site support group.
    Svikis D; McCaul M; Feng T; Stuart M; Fox M; Stokes E
    J Reprod Med; 1998 Sep; 43(9):799-805. PubMed ID: 9777620
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Social costs of robbery and the cost-effectiveness of substance abuse treatment.
    Basu A; Paltiel AD; Pollack HA
    Health Econ; 2008 Aug; 17(8):927-46. PubMed ID: 17992708
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cost-benefit and cost-effectiveness analysis of drug abuse treatment services.
    Cartwright WS
    Eval Rev; 1998 Oct; 22(5):609-36. PubMed ID: 10186896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.